Società BioPlus Acquisition Corp. Nasdaq
Azioni
BIOSU
KYG112171098
Società Holding
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Corporate Officer/Principal | 53 | - | |
Steven Fletcher
PRN | Corporate Officer/Principal | 56 | - |
Alex Serge Vieux
PRN | Corporate Officer/Principal | 66 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/12/21 |
Jonathan Rigby
CHM | Chairman | 56 | 01/07/21 |
Louis Lange
BRD | Director/Board Member | 72 | 01/12/21 |
Ronald Eastman
BRD | Director/Board Member | 71 | 01/12/21 |
Ross Haghighat
CEO | Chief Executive Officer | 60 | - |
Shawn Cross
BRD | Director/Board Member | 56 | 01/12/21 |
Glen Giovannetti
BRD | Director/Board Member | 61 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 5 750 000 | 0 | 0 | 29,61 % |
Azione B | 1 | 19 367 477 | 7 437 478 ( 38,40 %) | 0 |
Coordinate società
BioPlus Acquisition Corp.
260 Madison Avenue Suite 800
10016, New York
+
Variaz. 1 gen. | Capi. | |
---|---|---|
+173,89% | 6,65 Mrd | |
+2,29% | 981 Mln | |
+5,57% | 928 Mln | |
+41,91% | 872 Mln | |
+20,36% | 804 Mln | |
+1,72% | 664 Mln | |
-.--% | 600 Mln | |
-2,15% | 593 Mln | |
+40,25% | 552 Mln |